FY25 mckesson mat medications

Ended Awarded Last action

Contract number
15B30225F00000028
Awardee
Awarding agency
Obligated
$1,757,194

Award facts

Contract value 100% obligated
$1,761,193.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Irving, TX 75039, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action A00007 -$244,964
Funding Only Action A00006 $100,000
Funding Only Action A00005 $104,999
Funding Only Action A00004 $381,782
Other Administrative Action P00001 $4,000
Funding Only Action A00003 $200,000
Funding Only Action A00002 $252,781
Funding Only Action A00001 · Mckesson mat medications october to september 2025 fiscal year 2025 fund: 1060ADB / project: 90F RP#: 0079-25 $381,833
Original award $576,763

About this award

McKesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a delivery order valued at $1.76 million by the Federal Correctional Complex Coleman on November 8, 2024. This contract, designated as FY25 MCKESSON MAT MEDICATIONS, provides Medication-Assisted Treatment (MAT) medications to the correctional facility for the October 2024 through September 2025 fiscal year period. The award utilizes a firm fixed-price structure with no set-aside designation and is funded through the Bureau of Prisons' general medical supply appropriation (Fund 1060ADB). McKesson will deliver the ordered medications from its distribution center in Irving, Texas.

This delivery order represents continued engagement between McKesson and the Bureau of Prisons, a relationship characterized by the company's provision of controlled and non-controlled medications to multiple correctional facilities nationwide. The contract aligns with the Bureau of Prisons' comprehensive healthcare operations within its correctional complex system and reflects the agency's utilization of established vendor relationships for critical pharmaceutical supplies. As a large business contractor with no specific set-aside designation, McKesson was selected through a competitive federal procurement process, demonstrating its standing as a primary pharmaceutical distributor for federal correctional healthcare operations.

Quick answers

Who was awarded contract 15B30225F00000028?

15B30225F00000028 was awarded to Mckesson Corporation by Federal Correctional Complex Coleman (Correctional Facilities) on November 8, 2024.

How much is contract 15B30225F00000028 worth?

The government has obligated $1,757,194 on 15B30225F00000028. Its current value, with exercised options, is $1,761,194.

Is contract 15B30225F00000028 an order under another contract?

Yes. 15B30225F00000028 is a delivery order under 36W79720D0001, an indefinite delivery contract.

Was contract 15B30225F00000028 competed?

The extent of competition for 15B30225F00000028 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award